Amneal Pharmaceuticals (AMRX) Change in Account Payables (2017 - 2026)

Amneal Pharmaceuticals' Change in Account Payables history runs 10 years deep, the most recent figure standing at -$41.1 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 3556.76% year-over-year to -$41.1 million; the TTM figure through Mar 2026 stood at -$39.0 million (down 181.65% YoY), while the FY2025 annual figure was $931000.0, down 98.29% from the prior year.
• Change in Account Payables was -$41.1 million for Q1 2026 at Amneal Pharmaceuticals, down from -$2.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $34.1 million in Q4 2024 to a low of -$41.1 million in Q1 2026.
• Historically, Change in Account Payables has averaged $1.5 million across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Account Payables plunged 6605.33% in 2022, then jumped 1493.61% in 2023.
• A 5-year view of Change in Account Payables shows it stood at -$407000.0 in 2022, then surged by 1493.61% to $5.7 million in 2023, then surged by 501.23% to $34.1 million in 2024, then sank by 106.38% to -$2.2 million in 2025, then slumped by 1788.88% to -$41.1 million in 2026.
• The last three Change in Account Payables figures came in at -$41.1 million (Q1 2026), -$2.2 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.